CACYBP and familial pancreatic carcinoma: Similarly, CACYBP knockdown in pancreatic cancer inhibits cell growth by blocking the G1-to-S phase transition, mediated by the downregulation of Cyclin E, Cyclin A, and CDK2, along with the upregulation of p27ˆKip1 and Rb [29].